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( n = 14) and anthocyanin 1% treated mice ( n = 10.6,  p < 
0.001).  Conclusion: Anthocyanins prevented the formation 
and growth of colorectal cancer in AOM/DSS-treated Balb/c 
mice. Further studies should investigate the mechanisms of 
how anthocyanins influence the development of colorectal 
cancer.  © 2017 S. Karger AG, Basel 
 Introduction 
 Colorectal cancer is the second most common cancer 
in Europe and one of the main leading cause of cancer-
related deaths worldwide  [1, 2] . In 2012, 471,240 new 
CRC cases were diagnosed in Europe with a calculated 
incidence rate of 12.7%, leading to 228,275 deaths from 
CRC in the same time and area  [3] .
 Despite efforts for early diagnosis and new therapeutic 
approaches, there is an urgent need for preventive mea-
sures and therapies in high-risk populations.
 Regular physical activity, weight reduction for over-
weight persons and smoking cessation are recommended 
after a detailed review of the literature for the prevention 
of CRC  [4] . Although a specific diet recommendation is 
not given, current knowledge suggests that a high con-
sumption of fruit and vegetable is associated with a re-
duced risk of colorectal cancer  [5–7] .
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 Abstract 
 Background: Colorectal cancer is the main leading cause of 
cancer-related deaths worldwide. Present data suggest 
that plant-derived anthocyanins have anti-inflammatory 
and chemopreventive properties. This study was aimed at 
evaluating the effect of an anthocyanin-rich extract from 
bilberries on colorectal tumour development and growth 
in the administration of azoxymethan (AOM)/dextran so-
dium sulfate (DSS) mouse model.  Methods: Colonic carci-
nogenesis was induced by AOM and DSS 3 or 5%, respec-
tively, in 50 female Balb/c mice. Mice received either nor-
mal food (controls) or a diet containing either 10 or 1% 
anthocyanin-rich bilberry extract. Colonoscopy took place 
at week 4 and 9 after initiation of carcinogenesis. After ter-
mination at week 9, colon samples were analysed macro-
scopically and microscopically.  Results: Mice receiving 10% 
anthocyanins showed significantly ( p < 0.004) less reduced 
colon length (12.1 cm [8.5–14.4 cm]) as compared to con-
trols (11.2 cm [9.8–12.3]) indicating less inflammation. Mice 
fed with 10% anthocyanin-rich extract revealed significant-
ly less mean tumour numbers ( n = 1.2) compared to control 
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 Anthocyanins are naturally occurring flavonoids, 
which are responsible for the red, blue and purple colours 
of numerous fruits and vegetables. Present data demon-
strate that anthocyanins play a role in chemoprevention. 
Anthocyanins carry different glucosides such as glucose, 
galactose, arabinose and others. Deglycosylated anthocy-
anins are called anthocyanidins. Depending on their skel-
eton, there are also different types of anthocyanidin, that 
is, delphinidin, petunidin and cyanidin. The phenolic 
structure of anthocyanins is responsible for their antioxi-
dative activity, mainly due to their ability to scavenge re-
active oxygen species  [8] . Anthocyanins are also involved 
in the cell cycle, mainly regulatory proteins such as p53, 
which can additionally explain the anti-proliferative ef-
fect. In vitro studies confirm inhibitory effects on prolif-
eration, angiogenesis and induction of apoptosis in sev-
eral carcinoma cell lines (HT-29, CaCo-2 and HCT 116) 
 [9–12] . Furthermore, anthocyanins exhibited anti-in-
flammatory activity due to the inhibition of pro-inflam-
matory proteins such as nuclear factor-κB (NF-κB) and 
COX-2 in multiple cell types in vitro  [13] .
 In vivo studies using the APC (min) mouse model and 
the administration of azoxymethan (AOM)-induced 
model of colon cancer in F344 rats demonstrated reduced 
development of adenomas and cancer when anthocya-
nins were applied  [14–16] .
 This study was aimed at establishing murine endos-
copy in an AOM- and dextran sodium sulfate (DSS)-in-
duced model of colorectal cancer and in evaluating the 
effect of anthocyanins on tumour development.
 Methods 
 Animal Studies 
 Female Balb/c mice weighing 20–22 g (Charles River,  Germany) 
were used for the experiments and housed under conventional an-
imal facility conditions. Animals obtained food and water ad libi-
tum. The animal studies were approved by the local Institutional 
Review Board.
 Mice were fed with normal food supplemented with 1 or 10% 
anthocyanin-extract, respectively (Symrise, Germany). Control 
group received normal food.
 Two weeks before the induction of experimental colitis, this diet 
was started and given for the complete duration of the experiment.
 Carcinogenesis was induced by one-time injection of 10 μg 
AOM per g mouse i.p.. After 7 days, acute colitis was induced by 
giving 3 and 5% DSS in drinking water (MP Biomedicals, Illkirch, 
France) for 7 days. For induction of chronic colitis, mice received 
2 cycles of 3 or 5% DSS for 7 days interrupted by a period of 7 days 
with normal drinking water.
 We evaluated mice data (colonic length), macroscopic and mi-
croscopic findings (tumour size, number and localisation of tu-
mours).
 Colonoscopy 
 Colonoscopy was performed at weeks 4 and 9 after the initia-
tion of the experiment. Mice were anaesthetised using intraperito-
neal injection of xylazin hydrochloride (Bayer, Germany).
 For endoscopic evaluation, the “Coloview-system” (Karl Storz, 
Tuttlingen, Germany) was used  [17]. It consisted of a miniature 
endoscope (1.9 mm outer diameter), a triple chip camera and xe-
non light. Inflation of the mouse colon was achieved with warm 
water. Biopsies were taken for histological analysis using a flexible 
biopsy forceps with a diameter of 3 Fr.
 After the second endoscopy, mice were sacrificed as de-
scribed previously  [18] . Colon lengths were evaluated as a sign 
of inflammation. The overall number of tumours were counted 
and scored as follows: 0 = no sign of tumour, 1 = small, but de-
tectable tumour, 2 = tumour growth in up to half of the colon 
circumference, 3 = tumours larger than half of the colon circum-
ference.
 Assessment of Histology 
 Besides taking biopsies in living mice, the distal third of the co-
lon was removed after termination and used for histological anal-
ysis as described before  [19] . Cross-sections of the colon were fixed 
in 10% buffered formalin and stained with haematoxylin-eosin. 
Dysplastic proliferation of glandular epithelium on microscopic 
cross-sections of the colon was diagnosed and graded by an expe-
rienced pathologist (P.R.) as low-grade or high-grade dysplasia 
(LG-IEN/HG-IEN).
 Statistics 
 Colon lengths are given as mean and range. Statistical analyses 
were performed using the Student  t test and Mann–Whitney rank 
sum test. Statistically significant differences were accepted when 
 p  < 0.05.
 Results 
 Histology Reveals Colorectal Tumour Development in 
AOM DSS Mouse Model 
 Sections of the colon were analysed histologically. His-
tology confirmed the development of intraepithelial neo-
plasia with low-grade or high-grade dysplasia (LG-IEN/
HG-IEN) in mice treated with AOM/DSS as flat lesions 
or as dysplasia-associated lesion or mass as observed in 
human ( Fig. 1 a, b). Dysplasia-associated invasive carci-
noma was not observed.
 Anthocyanin-Treated Mice Develop Less Colonic 
Inflammation 
 The reduction of colon length caused by inflammation 
is a known feature of DSS colitis  [20] . Mice receiving 10% 
anthocyanins showed significantly ( p   < 0.004) less re-
duced colon length (12.1 cm [8.5–14.4 cm]) as compared 
to controls (11.2 cm [9.8–12.3]), indicating less inflam-
mation ( Fig. 2 ).
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
13
6 
- 1
/2
3/
20
18
 2
:5
5:
22
 P
M
 Anthocyanins Prevent Colorectal Cancer Digestion 2017;95:275–280
DOI: 10.1159/000475524
277
8
10
12
14
16
Co
lon
 len
gth
, cm
Control Anthocyanin
1%
Anthocyanin
10%
p < 0.004
 Fig. 1.  a Histology confirmed the development of intraepithelial 
neoplasia for all groups. There was no difference with respect to 
low-grade or high-grade dysplasia (LG-IEN/HG-IEN). Dysplasia-
associated invasive carcinoma was not observed.  b Biopsy sam-
pling of a tumour during endoscopy confirmed high-grade in-
traepithelial neoplasia. 
 Fig. 2. The colon length as a sign of inflammation was significant-
ly enlarged in the 10% anthocyanin group indicating less inflam-
mation compared to the control group. 
 Fig. 3. In vivo high resolution endoscopy of a tumour up to a half 
of the colonic circumference and additional biopsy forceps. 
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 Anthocyanin-Treated Mice Have Macroscopically Less 
Tumours in the Colon 
 The number and size of tumours were evaluated mac-
roscopically by colonoscopy at weeks 4 and 9 by 2 inde-
pendent investigators. A total of 50 mice were included. 
One mouse from the 10% anthocyanin treatment group 
died during endoscopy. Control mice had no normal mu-
cosa that were detectable during endoscopy, while in 1% 
treated mice, tumours were macroscopically less in num-
ber and size. The 10% treated mice had macroscopically 
almost no tumours that were detectable.  Figure 3 shows 
a representative endoscopic picture of a tumour covering 
up to a half of the colonic circumference with biopsy for-
ceps.
 Becker et al. [17] developed endoscopic tumour scor-
ing based on the number and size of tumours. In our 
study, we could reconfirm this scoring system during en-
doscopic examination, but we evaluated the number and 
size of tumours in detail at the end of the experiment 
( Fig. 4 a–c).
 Figure 5 shows median numbers of tumours depend-
ing on the tumour size for each group. Mice fed with 
10% anthocyanin-rich extract revealed significantly less 
mean tumour numbers ( n  = 1.2) compared to control 
( n  = 14) and anthocyanin 1% treated mice ( n  = 10.6,  p  < 
0.001).
 Discussion 
 We studied the effect of dietary anthocyanins in an in-
flammation driven colorectal cancer mouse model. Dur-
ing the study period of 10 weeks, anthocyanin supple-
mentation of the diet was followed by a smaller tumour 
size in 1% and dramatically less and smaller tumours in 
10% anthocyanin-treated mice compared to the control 
 Fig. 4. Anthocyanin-treated mice show less 
tumours macroscopically compared to the 
control group. Exemplarily, one colon of 
each group at the end of the experiment is 
shown ( a control group,  b anthocyanin 1%, 
 c anthocyanin 10%). 
0
0.5
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2.0
2.5
3.0
Tum
or 
siz
e (
0–3
)
Control 1% 10%
p < 0.001
p < 0.001
 Fig. 5. Tumour sizes were evaluated for all groups. Mice fed with 
anthocyanins 10% revealed significantly less tumours compared to 
both control and anthocyanin 1% treated mice. 
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group. In addition, the anthocyanin diet prevented in-
flammation-induced reduction of colon length in 10% 
anthocyanin-treated mice compared to control mice.
 So far, the exact mechanisms of how anthocyanins can 
inhibit colorectal cancer development are not completely 
clear.
 In our model of cancer, histology reveals the develop-
ment of intraepithelial neoplasia in all macroscopically 
documented tumours. No carcinoma could be found. 
Therefore, one could speculate that the follow up time 
was probably too short.
 In vitro, anthocyanin extracts have an inhibitory effect 
on cancer cell proliferation via p21 and Bax  [21] . Antho-
cyanins were also able to inhibit cell growth and are an 
inducer of cell apoptosis in colon cancer cells by modulat-
ing DNA damage  [22–24] , inducing a cell cycle arrest  [12, 
25] or are responsible for demethylation of tumour sup-
pressor genes  [26] .
 The findings on the prevention of colonic inflamma-
tion induced by DSS are in line with earlier experiments 
of our lab where we could demonstrate that anthocyanins 
have anti-inflammatory properties and ameliorate DSS-
induced chronic colitis  [27] . In human monocytic THP-1 
cells, bilberry extract reduced interferon-γ (IFN-γ)-
induced signal protein activation, pro-inflammatory 
gene expression and cytokine secretion, and enhanced tu-
mor necrosis factor-α (TNF-α)-induced responses  [28] . 
Even a recent study on biopsy samples of patients with 
ulcerative colitis treated with an oral anthocyanin-rich 
bilberry preparation during an open label clinical trial re-
vealed reduced amounts of the proinflammatory cyto-
kines IFN-γ and TNF-α  [29] .
 Anthocyanins have been reported to reduce both in-
flammation and tumour development via downregulation 
of proinflammatory enzymes and suppression of NF-κB 
or VCAM-1 on both mRNA and protein level  [30] . In 
vivo, anthocyanins were also found to be protective by in-
ducing a cell cycle arrest and having an anti-proliferative 
effect  [25] similar to the so-far known in vitro findings.
 A human pilot study of oral anthocyanins as chemo-
prevention in colorectal cancer used mirtocyan, a mix-
ture of anthocyanins from bilberry extract. Thomasset et 
al. [31] showed a reduction in proliferation index by 7% 
and anthocyanin appearing in plasma, colorectal tissue 
and urine. Furthermore, anthocyanidins may possibly 
play a role as sensitizing agents in colorectal cancer ther-
apy  [32] . Cvorovic et al. [32] tested cytotoxicity of antho-
cyanidins in primary (Caco-2) and metastatic (LoVo and 
LoVo/ADR) colorectal cancer cell lines. They could dem-
onstrate that anthocyanidins had a strong cytotoxic effect 
in the metastatic drug-resistant cell line (LoVo/ADR).
 In conclusion, we could demonstrate a protective role 
of anthocyanins in the development of CRC. We showed 
that anthocyanins reduced colon cancer development in 
our model, indicating that both mechanisms (inflamma-
tion and cell growth) are simultaneously influenced by 
anthocyanins. Murine high resolution endoscopy enables 
monitoring colorectal carcinogenesis and the effects of 
anthocyanins on tumour development over a continuous 
period. Furthermore, colonic biopsies were suited for his-
tological analysis.
 However, further studies are warranted to clarify the 
exact mechanisms of how anthocyanins can contribute to 
the prevention of colon cancer in this new model of high 
resolution endoscopic system. In the future, biopsy sam-
ples could also be used for immunological and molecular 
analysis.
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